LONDON, May 17 (Reuters) - GlaxoSmithKline Plc’s (GSK.L: Quote, Profile, Research) chief executive has extended his term at the head of Europe’s biggest drugmaker and said the group would maintain its British base, despite threats from animal-rights activists.
